Cara Therapeutics reported $50K in Ordinary Share Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Acelrx Pharmaceuticals ACRX:US $ 0.12M 0M
Aerie Pharmaceuticals AERI:US $ 0.05M 0M
Arena Pharmaceuticals ARNA:US $ 0.01M 0M
Biodelivery Sciences International BDSI:US $ 0.1M 0M
Cara Therapeutics CARA:US $ 50K 0
Chugai Pharma 4519:JP Y 73202M 0M
Depomed DEPO:US $ 0M 0M
Endo International Ordinary Shares ENDP:US $ 0.07M 0M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Horizon Pharma HZNP:US $ 0.02M 0M
JAZZ PHA JAZZ:US $ 0.06M 0M
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Pacira Pharmaceuticals PCRX:US $ 0.04M 0M
Pain Therapeutics PTIE:US $ 460.7M 0.65M
Redhill Biopharma RDHL:US $ 1.31M 0M
Revance Therapeutics RVNC:US $ 0.07M 0M
Supernus Pharmaceuticals SUPN:US $ 0.05M 0M
Teva Pharmaceutical Industries TEVA:US $ 57M 0M
Vanda Pharmaceuticals VNDA:US $ 0.06M 0M